Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
09/2012
09/27/2012US20120244070 Fibronectin targeting contrast agent
09/27/2012CA2830772A1 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy
09/27/2012CA2830325A1 Cyclic peptides with an anti-neoplasic and anti-angiogenic activity
09/27/2012CA2830259A1 Peptides for suppressing inflammation
09/26/2012EP2501722A1 Method for producing t cell receptor-like monoclonal antibodies and uses thereof
09/26/2012EP2501715A1 Template-fixed peptidomimetics with ccr10 antagonistic activty
09/26/2012EP2501714A1 Heteropeptides useful for reducing nonspecific adsorption
09/26/2012EP2501711A1 Compounds and methods for purifying peptides produced by solid phase peptide synthesis
09/26/2012EP2501396A1 LOW ANTIGEN-DOSE IMMUNIZATION FOR MAXIMIZING T-HELPER CELL 1 (T h1) IMMUNITY AGAINST DISEASE
09/26/2012CN102695722A Antibodies and epitopes specific to misfolded prion protein
09/26/2012CN102690344A Use of pedf-derived polypeptides for promoting stem cells proliferation and wound healing
09/26/2012CN102690329A Purification production method of goserelin polypeptide
09/26/2012CN102690328A Single photon emission computed tomography developer and preparation method thereof
09/26/2012CN102690327A Enterovirus 71 neutralized epitope polypeptide and application thereof
09/26/2012CN102690326A Novel gossypol derivate with anti-HIV activity and preparation method thereof
09/26/2012CN102690244A Substances regulating alpha-synuclein accumulation and its pharmaceutical application
09/26/2012CN101962400B Linear epitope minimum motif peptide of human papilloma virus type 58 L1 protein and application thereof
09/25/2012CA2664137C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
09/25/2012CA2522994C Nucleic acids and corresponding proteins entitled 109p1d4 useful in treatment and detection of cancer
09/25/2012CA2512310C Improved linkers for radiopharmaceutical compounds
09/25/2012CA2482598C Peptide inhibitors of protein kinase c
09/25/2012CA2466591C Template-fixed peptidomimetics as inhibitors of serine proteases
09/20/2012WO2012124683A1 Novel monoclonal antibody and use thereof as tag antibody
09/20/2012WO2012123957A1 Oligopeptides and process for preparation thereof
09/20/2012WO2012123495A2 Functionalized biomaterials for tissue regeneration
09/20/2012WO2012123018A1 Functionalized biomaterials for tissue regeneration
09/20/2012WO2012122943A1 Anti-hepatitis b virus x protein polypeptide drug
09/20/2012WO2012122942A1 Polypeptide drug against hepatitis b virus x protein
09/20/2012WO2012122941A1 Polypeptide drug against hepatitis b virus x protein
09/20/2012WO2012122930A1 Lhrh antagonist derivative, and preparation method and applications thereof
09/20/2012US20120238507 Alpha helical mimics, their uses and methods for their production
09/20/2012US20120238503 Human laminin alpha2 chain lg3 domain and active peptides promoting cell adhesion, spreading, migration, and neurite outgrowth
09/20/2012US20120238490 Methods and compositions for the treatment of metabolic disorders
09/20/2012US20120237947 Glutathione S-Transferase Omega 1 Wild Type Specific Antibody
09/20/2012US20120237614 Peptide able to disrupt the protein complex between the his273 mutaded p53 protein and the oncosuppressive p73 protein in tumor cells and therapeutic uses thereof
09/20/2012US20120237537 Methods for producing an immune response to tuberculosis
09/20/2012US20120237501 Anti-HIV Peptides and Methods of Use Thereof
09/20/2012US20120237444 Iodine radiolabelling method
09/20/2012CA2830235A1 Multiplexed detection with isotope-coded reporters
09/19/2012EP2500350A2 Composite of a protein comprising zinc oxide-bonding peptides and zinc oxide nanoparticles, and use thereof
09/19/2012EP2500040A1 Improved Gastrin Releasing Peptide Receptor-Binding Compounds
09/19/2012EP2499155A1 Antibiofilm glycopeptides
09/19/2012EP2499154A1 Treatments for gastrointestinal disorders
09/19/2012EP2498794A1 Method of treatment of type 2 diabetes
09/19/2012EP2498601A1 N-terminal dimerization methods with bis-amindino acid-and bis-thioimidate derivatives
09/19/2012CN102686603A Peptides imparting cell permeability to lipid membrane structure and/or enhancing cell permeability of lipid membrane structure, and lipid membrane structure comprising lipid bound to such peptide as constituent lipid and having cell permeability or showing enhanced cell permeability
09/19/2012CN102686234A Composition for improving brain function and method for improving brain function
09/19/2012CN102675458A Monoclonal antibodies and methods for their use in the detection of cervical disease
09/19/2012CN102675429A Virus capping system polypeptide inhibitor for controlling coronavirus
09/19/2012CN102675427A High-pressure liquid-phase preparation method for enramycin standard sample
09/19/2012CN102675426A Extraction and purification method of daptomycin
09/19/2012CN102675425A Functional mycobacterium tuberculosis antigen polypeptide and application thereof
09/19/2012CN102675424A Polypeptide drug for resisting Hepatitis B virus X protein
09/19/2012CN102675423A Polypeptide medicine against hepatitis B virus X protein
09/19/2012CN102675422A Polypeptide drug against hepatitis B virus X protein (HBx)
09/19/2012CN102675421A Epitope peptide of heat shock protein and application thereof
09/19/2012CN102675420A Synthetic decapeptide and method for promoting generation of fish yolk
09/19/2012CN102675419A Abeta oligopeptide polymerization inhibitor and preparation and application thereof
09/19/2012CN102675418A Luteinizing hormone-releasing hormone (LHRH) antagonist derivative, preparation method of LHRH antagonist derivative and application of LHRH antagonist derivative
09/19/2012CN102671181A High purity lipopeptides, lipopeptide micelles and processes for preparing same
09/19/2012CN102010884B Antibacterial active matter as well as preparation method and application thereof
09/19/2012CN101906142B Carboline carboxylic acid-tetrapeptide conjugate and synthesis method as well as medical application thereof
09/19/2012CN101544688B Cyclo-pentapeptide apoptosis enzyme inhibitor and method for preparing same
09/18/2012US8268784 Neuropeptide-2 receptor (Y-2R) agonists and uses thereof
09/18/2012US8268774 Method for reducing pain
09/18/2012US8268576 Diagnosis of autism
09/18/2012CA2533321C Bicyclic peptide imaging agents
09/18/2012CA2514303C Synthetic single domain polypeptides mimicking apolipoprotein e and methods of use
09/18/2012CA2462610C Specific binding agents of human angiopoietin-2
09/18/2012CA2443702C Echinocandin process
09/18/2012CA2410662C Novel peptides as ns3-serine protease inhibitors of hepatitis c virus
09/13/2012WO2012122059A1 Hydrogen bond surrogate macrocycles as modulators of ras
09/13/2012WO2012121058A1 Pharmaceutical composition that uses novel peptide that mimics tnf receptor loop peptide containing cross-linked structure
09/13/2012WO2012121057A1 Novel cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
09/13/2012WO2012077037A3 PEPTIDES THAT MODULATE COMPLEX SASPase-FLG2
09/13/2012US20120232249 Method of modulating integrin mediated cellular activity and agents useful for same
09/13/2012US20120232248 Therapeutic agent for pulmonary small cell carcinoma
09/13/2012US20120232012 Compositions having antiangiogenic activity and uses thereof
09/13/2012US20120231996 Phalloidin derivatives and methods for their synthesis
09/13/2012US20120231994 Antagonism of human formyl peptide receptor for treatment of disease
09/13/2012US20120231026 Methods and compositions for tumor vaccination and therapy
09/13/2012US20120230994 Bladder cancer specific ligand peptides
09/13/2012DE102011013326A1 Neue Fibrinolyse-Inhibitoren und deren mdizinische Verwendung New fibrinolysis inhibitors and their use mdizinische
09/13/2012CA2828889A1 Hydrogen bond surrogate macrocycles as modulators of ras
09/12/2012EP2497784A1 Peptide capable of promoting cell proliferation, and use thereof
09/12/2012EP2497777A2 Mutant double cyclized receptor peptides inhibiting beta 1-adrenoceptor antibodies
09/12/2012EP2496947A1 Positively charged species as binding reagents in the separation of protein aggregates from monomers
09/12/2012EP2496596A1 Therapeutic peptides
09/12/2012CN102666576A Peptides that bind the alpha-fetoprotein (AFP) receptor and uses thereof
09/12/2012CN102666565A Compounds and methods for purifying peptides produced by solid phase peptide synthesis
09/12/2012CN102659946A Anti-alpha v beta 6 antibodies
09/12/2012CN102659930A High-purity cyclopeptide crystal and its preparation method and use
09/12/2012CN102659929A Transient receptor potential channel-6 (TRPC6) antigen polypeptide and anti-TRPC6 monoclonal antibody
09/12/2012CN102659928A Synthetic signal peptide and application thereof
09/12/2012CN102659927A Synthetic signal peptide and application thereof
09/12/2012CN102659926A Pc-E polypeptide inhibiting aspergillus fumigatus from adhering to cornea
09/12/2012CN102659925A Human oocyte zona pellucida (ZP)-4 epitope minimum motif peptide identified by anti-recombinant human ZP4N and ZP4C polyclonal antibody
09/12/2012CN102659924A HLA-A*1101-restricted WT1 peptide and pharmaceutical composition comprising the same
09/12/2012CN102659923A Epitope minimal motif peptides of human zona pellucida protein-4 and extended short peptides and application thereof
09/12/2012CN102659922A Peptide Derived From Hepatitis C Virus
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 423